A current model for predicting the risk of cardiovascular diseases in patients with type 2 diabetes mellitus

被引：0
|
作者：
Biryukova, E. V. [1 ]
机构：
[1] Moscow State Univ Med & Dent, Minist Hlth & Social Dev Russia, Moscow, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2012年 / 84卷 / 10期
关键词：
type 2 diabetes mellitus; ADVANCE trial; cardiovascular risk prediction scale; sugar-lowering therapy; BLOOD-GLUCOSE CONTROL; OUTCOMES; COMPLICATIONS; PREVALENCE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Type 2 diabetes mellitus (T2DM) is a severe progressive disease complicating the development of micro- and macrovascular complications that result in early disability, including that in able-bodied persons, a reduction in the patients' life, and its worse quality. The author discusses the new scale developed according to the results of the ADVANCE trial for predicting the cardiovascular risk in patients with T2DM which may be used widely in these patients to estimate the risk of cardiovascular events and as a tool to assist in determining the intensity of treatment. She considers current approaches to treating T2DM, by using the results of the ADVANCE trial.
引用
收藏
页码：98 / 102
页数：5
相关论文
共 50 条
  • [1] ASSESSMENT OF CARDIOVASCULAR DISEASES RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Jose, C.
    VALUE IN HEALTH, 2017, 20 (05) : A351 - A351
  • [2] CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE
    Sapozhnikova, I. E.
    Tarlovskaya, E. I.
    Anufrieva, E. N.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2009, 5 (03) : 8 - 13
  • [3] IMPACT OF ANTIDIABETIC THERAPY ON THE RISK OF CARDIOVASCULAR DISEASES AND THEIR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Ametov, A. S.
    Pyanykh, O. P.
    Chernikova, N. A.
    TERAPEVTICHESKII ARKHIV, 2010, 82 (08): : 71 - 75
  • [4] Cardiovascular risk factors in patients with type 2 diabetes mellitus
    Carolina Vintimilla, Evelin
    Vintimilla Molina, Jhojana Rosati
    Carmendel Rocio Parra
    Martinez Santander, Diana Antonieta
    Martinez Santander, Carlos Jose
    del Rocio Andrade, Neida
    Cumbe Guerrero, Karla Maria
    Cardenas Heredia, Fredy Rosendo
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2018, 13 (04): : 356 - 360
  • [5] Reducing cardiovascular risk in patients with type 2 diabetes mellitus
    Nicholls, Stephen J.
    Ryden, Lars
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2010, 17 : S1 - S1
  • [6] Cardiovascular risk in type 2 diabetes mellitus
    Hohberg, C.
    Roth, W.
    Luebben, G.
    Forst, T.
    Gauert, S.
    Karagiannis, F.
    Reimer, T.
    Gottschall, V.
    Pfuetzner, A.
    DIABETES STOFFWECHSEL UND HERZ, 2007, 16 (03): : 173 - 177
  • [7] RISK OF CARDIOVASCULAR DISEASES IN PEOPLE WITH TYPE 1 DIABETES MELLITUS
    Chalakova, Tatyana
    Yotov, Yoto
    Tsochev, Kaloyan
    Bocheva, Yana
    Iotova, Violeta
    Usheva, Natalya
    Galcheva, Sonya
    Valchev, Georgi
    JOURNAL OF HYPERTENSION, 2021, 39 : E177 - E178
  • [8] Leptin, cardiovascular diseases and type 2 diabetes mellitus
    Katsiki, Niki
    Mikhailidis, Dimitri P.
    Banach, Maciej
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (07): : 1176 - 1188
  • [9] Leptin, cardiovascular diseases and type 2 diabetes mellitus
    Niki Katsiki
    Dimitri P Mikhailidis
    Maciej Banach
    Acta Pharmacologica Sinica, 2018, 39 : 1176 - 1188
  • [10] Prediction models for the risk of cardiovascular diseases in Chinese patients with type 2 diabetes mellitus: a systematic review
    Dong, W.
    Wan, E. Y. F.
    Bedford, L. E.
    Wu, T.
    Wong, C. K. H.
    Tang, E. H. M.
    Lam, C. L. K.
    PUBLIC HEALTH, 2020, 186 : 144 - 156
12345